Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Aclaris Therapeutics, Inc.
INTERNAL ADDRESS
Suite 200
*STREET
640 Lee Road
*CITY
Wayne
*STATE
(Required for U.S. applicants)
Pennsylvania
*COUNTRY
United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
19087
LEGAL ENTITY INFORMATION
TYPE
corporation
STATE/COUNTRY OF INCORPORATION
Delaware
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
042
*IDENTIFICATION
Research and development of pharmaceutical preparations, products and technology in the fields of dermatology; providing medical and
scientific research information in the fields of dermatology, pharmaceuticals and clinical trials; drug discovery services
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88372841
Filing Date:04/05/2019
To the Commissioner for Trademarks:
MARK: KINect (Standard Characters, see mark)
The literal element of the mark consists of KINect.
The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Aclaris Therapeutics, Inc., a corporation of Delaware, having an address of
Suite 200
640 Lee Road
Wayne, Pennsylvania 19087
United States
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 042: Research and development of pharmaceutical preparations, products and technology in the fields of dermatology; providing medical
and scientific research information in the fields of dermatology, pharmaceuticals and clinical trials; drug discovery services
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
The applicant's current Attorney Information:
Darius C. Gambino of DLA Piper LLP (US)
Suite 4900
1650 Market Street
Philadelphia, Pennsylvania 19103
United States
215-656-3309(phone)
darius.gambino@dlapiper.com (authorized)
The attorney docket/reference number is ACT-19-1192.
The applicant's current Correspondence Information:
Darius C. Gambino
DLA Piper LLP (US)
Suite 4900
1650 Market Street
Philadelphia, Pennsylvania 19103
215-656-3309(phone)
darius.gambino@dlapiper.com;pto.phil@dlapiper.com (authorized) E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at
the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent
application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional
processing fee of $125 per international class of goods/services.
A fee payment in the amount of $275 has been submitted with the application, representing payment for 1 class(es).
Declaration
Declaration Signature
Signature: /dcg/ Date: 04/05/2019
Signatory's Name: Darius C. Gambino
Signatory's Position: Attorney of Record, PA Bar Member
Payment Sale Number: 88372841
Payment Accounting Date: 04/05/2019
Serial Number: 88372841
Internet Transmission Date: Fri Apr 05 10:41:02 EDT 2019
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.X-2019040510410255
4017-88372841-620f29ed9106fd64e0b99db4bf
27adfe7a7434d7c8d6ca2195863d09f3e4c60f4-
DA-7918-20190405103115454031